- Home
- /
- Treatment
- /
- Page 146
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Oxandrolone | Short stature associated with Turner's syndrome | Bio-Technology General Corp.;70 Wood Avenue, South;Iselin, New Jersey, 08830 | July 5, 1990 |
|
|
Sodium dichloroacetate | Homozygous familial hypercholesterolemia | Stacpoole, Peter W. M.D., Ph.D.;University of Florida, P.O. Box 100277;Gainesville, Florida, 32610 | June 11, 1990 |
|
|
Sodium dichloroacetate | Congenital lactic acidosis | Stacpoole, Peter W. M.D., Ph.D.;University of Florida, P.O. Box 100277;Gainesville, Florida, 32610 | June 11, 1990 |
|
|
Calcium carbonate | Hyperphosphatemia | R & D Laboratories, Inc.;4204 Glencoe Avenue;Marina Del Rey, California, 90292 | June 6, 1990 |
|
|
Amifostine | For use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma | Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 | May 30, 1990 |
|
|
Amifostine | For use as a chemoprotective agent for cyclophosphamide in the treatment of advanced ovarian carcinoma | Clinigen Group plc;Pitcairn House, Crown Square, DE14 2WW; | May 30, 1990 |
|
|
Amifostine | For use as a chemoprotective agent for cisplatin in the treatment of metastatic melanoma | Clinigen Group plc;Pitcairn House, Crown Square, DE14 2WW; | May 30, 1990 |
|
|
PR-225 (redox-acyclovir) | Herpes simplex encephalitis | Pharmos;2 Innovation Drive;Alachua, Florida, 32615 | May 29, 1990 |
|
|
Short chain fatty acid solution | Ulcerative colitis | Richard I. Breuer;1000 Central Street, Suite 615;Evanston, Illinois, 60201 | May 29, 1990 |
|
|
His-D-Trp-Ala-Trp-D-Phe-Lys NH2 | For the long term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion | SmithKline Beecham Pharmaceuticals;One Franklin Plaza;Philadelphia, Pennsylvania, 19101 | May 23, 1990 |
|
|
PR-239 (redox penicillin G) | AIDS associated neurosyphilis | Pharmos;2 Innovation Drive;Alachua, Florida, 32615 | May 23, 1990 |
|
|
Interferon alfa-2a (recombinant) | For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110 | May 14, 1990 |
|
|
Iloprost solution for infusion | Heparin-associated thrombocytopenia | Berlex Laboratories, Inc.;300 Fairfield Road;Wayne, New Jersey, 07470 | May 14, 1990 |
|
|
Interleukin-2 | In combination with interferon alfa-2a for the treatment of metastatic malignant melanoma | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07119 | May 11, 1990 |
|
|
Interferon alfa-2a (recombinant) | Metastatic Melanoma | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07119 | May 11, 1990 |
|
|
Somatropin | Short stature associated with Turner syndrome | Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 | May 8, 1990 |
|
|
Group B streptococcus immune globulin | Neonates for disseminated group B streptococcal infection | North American Biologicals, Inc.;12280 Wilkins Avenue;Rockville, Maryland, 20852 | May 8, 1990 |
|
|
Interferon alfa-2b (recombinant) | Chronic delta hepatitis | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | May 4, 1990 |
|
|
Granulocyte macrophage-colony stimulating factor | Chronic lymphocytic leukemia | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | May 4, 1990 |
|
|
Sargramostim | Neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment | Immunex Corporation;51 University Street;Seattle, WA, 98101 | May 3, 1990 |
|
|
Interleukin-2 | In combination with interferon alfa-2a for the treatment of metastatic renal cell carcinoma | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07119 | May 3, 1990 |
|
|
Sargramostim | Neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment | Immunex Corporation;51 University Street;Seattle, Washington, 98101 | May 3, 1990 |
|
|
Anti-cytomegalovirus monoclonal antibodies | Human cytomegalovirus infection in patients diagnosed with AIDS | Biomedical Research Institute;345 North Smith Avenue;St. Paul, MN, 55102 | May 3, 1990 |
|
|
Anti-cytomegalovirus monoclonal antibodies | 1. human cytomegalovirus infection in patients diagnosed with AIDS 2. Prevention of human cytomegalovirus infection in patients diagnosed with AIDS | Biomedical Research Institute;345 North Smith Avenue;St. Paul, Minnesota, 55102 | May 3, 1990 |
|
|
Granulocyte macrophage-colony stimulating factor | Neutropenia due to hairy cell leukemia | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 | May 3, 1990 |